SIM
VRTX icon

SSI Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

SSI Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,625
Closed -$204K – 279
2015
Q4 		$204K Buy
+1,625
New +$196K 0.02% 266
2014
Q2 		– Sell
-3,190
Closed -$226K – 413
2014
Q1 		$226K Sell
3,190
-5,153
-62% -$408K 0.02% 365
2013
Q4 		$619K Buy
+8,343
New +$581K 0.05% 309

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SSI Investment Management's VRTX Position: Q1 2016 in Review

SSI Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2016, closing a stake of 1,625 shares — an estimated $204K sold.

SSI Investment Management first reported a position in VRTX in Q4 2013 and held it in 3 quarters. The position peaked at $619K in Q4 2013. 502 funds tracked by Wall St. Rank hold VRTX as of Q1 2016.

  • SSI Investment Management reported no remaining Vertex Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • SSI Investment Management sold 1,625 Vertex Pharmaceuticals shares in Q1 2016, an estimated $204K.
  • SSI Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • SSI Investment Management's Vertex Pharmaceuticals position peaked at $619K in Q4 2013.
  • 502 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2016.

Based on SSI Investment Management's 13F filing for Q1 2016, filed 9 May 2016.